PureTech Health (PRTC) Total Non-Current Liabilities (2019 - 2025)
PureTech Health (PRTC) reported Total Non-Current Liabilities of $182.7 million for Q4 2025, up 19.18% year-over-year from $153.3 million in Q4 2024, and up 27.21% quarter-over-quarter from $143.6 million in Q2 2025.
PureTech Health (PRTC) Total Non-Current Liabilities (2019 - 2025) Analysis & Trends
PureTech Health (PRTC) has 7 years of Total Non-Current Liabilities data on file, last reported at $182.7 million in Q4 2025.
- Total Non-Current Liabilities for Q4 2025 came in at $182.7 million, up 19.18% year-over-year; the trailing twelve-month figure through Dec 2025 was $182.7 million (up 19.18% YoY), and the FY2025 annual result was $182.7 million, up 19.18% from the prior year.
- Total Non-Current Liabilities rose to $182.7 million in Q4 2025 per PRTC's latest filing, from $143.6 million in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $184.4 million in Q4 2023 and troughed at $58.2 million in Q4 2022.
- A 5-year average of $141.9 million and a median of $143.6 million in 2025 frame the typical range for Total Non-Current Liabilities.
- The sharpest annual moves came in 2022 and 2023: Total Non-Current Liabilities plunged 57.14% in 2022, then surged 216.94% in 2023.
- A 5-year view of Total Non-Current Liabilities shows it stood at $135.7 million in 2021, then sank by 57.14% to $58.2 million in 2022, then surged by 216.94% to $184.4 million in 2023, then decreased by 16.84% to $153.3 million in 2024, then advanced by 19.18% to $182.7 million in 2025.
- Business Quant data shows PRTC's Total Non-Current Liabilities at $182.7 million in Q4 2025, $143.6 million in Q2 2025, and $153.3 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 11.03 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 95.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 644,700.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 5.87 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 64.76 Mn |
| 10 | PureTech Health | 86.36 Mn | -190.94 Mn | - | 182.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 182.73 Mn |
| Jun 30, 2025 | 143.64 Mn |
| Dec 31, 2024 | 153.31 Mn |
| Jun 30, 2024 | 135.43 Mn |
| Dec 31, 2023 | 184.37 Mn |
| Dec 31, 2022 | 58.17 Mn |
| Dec 31, 2021 | 135.73 Mn |
| Dec 31, 2020 | 155.53 Mn |
| Dec 31, 2019 | 151.58 Mn |